Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Dextrose Prolotherapy for Chronic Shoulder Pain: A Case Report.

Seenauth C, Inouye V, Langland JO.

Altern Ther Health Med. 2018 Jan;24(1):56-60.

PMID:
29101774
2.

The Use of Intravenous Glutathione for Symptom Management of Parkinson's Disease: A Case Report.

Otto M, Magerus T, Langland JO.

Altern Ther Health Med. 2018 Jul;24(4):56-60.

PMID:
29101773
3.

Characterization of a PKR inhibitor from the pathogenic ranavirus, Ambystoma tigrinum virus, using a heterologous vaccinia virus system.

Huynh TP, Jancovich JK, Tripuraneni L, Heck MC, Langland JO, Jacobs BL.

Virology. 2017 Nov;511:290-299. doi: 10.1016/j.virol.2017.08.012. Epub 2017 Sep 14.

4.

Treatment of Athlete's Plantar Warts Using a Botanical Blend: A Case Report.

Nelson EO, Kozin AF, Ruiz G, Lasku A, Langland JO.

Altern Ther Health Med. 2017 May;23(3):51-54. Epub 2017 Feb 27.

PMID:
28236614
5.

A Lack of Bioactive Predictability for Marker Compounds Commonly Used for Herbal Medicine Standardization.

Ruiz GG, Nelson EO, Kozin AF, Turner TC, Waters RF, Langland JO.

PLoS One. 2016 Jul 26;11(7):e0159857. doi: 10.1371/journal.pone.0159857. eCollection 2016.

6.

In vitro characterization of a nineteenth-century therapy for smallpox.

Arndt W, Mitnik C, Denzler KL, White S, Waters R, Jacobs BL, Rochon Y, Olson VA, Damon IK, Langland JO.

PLoS One. 2012;7(3):e32610. doi: 10.1371/journal.pone.0032610. Epub 2012 Mar 9.

7.

Use of a negative selectable marker for rapid selection of recombinant vaccinia virus.

White SD, Conwell K, Langland JO, Jacobs BL.

Biotechniques. 2011 May;50(5):303-9. doi: 10.2144/000113667.

8.
9.

Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals.

Denzler KL, Waters R, Jacobs BL, Rochon Y, Langland JO.

PLoS One. 2010 Sep 3;5(9):e12561. doi: 10.1371/journal.pone.0012561.

10.

Vaccinia virus vaccines: past, present and future.

Jacobs BL, Langland JO, Kibler KV, Denzler KL, White SD, Holechek SA, Wong S, Huynh T, Baskin CR.

Antiviral Res. 2009 Oct;84(1):1-13. doi: 10.1016/j.antiviral.2009.06.006. Epub 2009 Jun 26. Review.

11.

Protein kinase PKR-dependent activation of mitogen-activated protein kinases occurs through mitochondrial adapter IPS-1 and is antagonized by vaccinia virus E3L.

Zhang P, Langland JO, Jacobs BL, Samuel CE.

J Virol. 2009 Jun;83(11):5718-25. doi: 10.1128/JVI.00224-09. Epub 2009 Mar 25.

12.

Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination.

Jentarra GM, Heck MC, Youn JW, Kibler K, Langland JO, Baskin CR, Ananieva O, Chang Y, Jacobs BL.

Vaccine. 2008 Jun 2;26(23):2860-72. doi: 10.1016/j.vaccine.2008.03.044. Epub 2008 Apr 8.

13.

Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist.

Ye Y, Hauns K, Langland JO, Jacobs BL, Hogue BG.

J Virol. 2007 Mar;81(6):2554-63. Epub 2006 Dec 20.

14.
15.

Inhibition of PKR by RNA and DNA viruses.

Langland JO, Cameron JM, Heck MC, Jancovich JK, Jacobs BL.

Virus Res. 2006 Jul;119(1):100-10. Epub 2006 May 15. Review.

PMID:
16704884
16.

Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L.

Langland JO, Jacobs BL.

Virology. 2004 Jul 1;324(2):419-29.

17.

Regulation of IL-2 gene expression and nuclear factor-90 translocation in vaccinia virus-infected cells.

Langland JO, Kao P, Jacobs BL.

J Interferon Cytokine Res. 2003 Sep;23(9):489-500.

PMID:
14565858
18.

The Orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo.

Vijaysri S, Talasela L, Mercer AA, Mcinnes CJ, Jacobs BL, Langland JO.

Virology. 2003 Sep 15;314(1):305-14.

19.
20.

Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A.

He Y, Tan SL, Tareen SU, Vijaysri S, Langland JO, Jacobs BL, Katze MG.

J Virol. 2001 Jun;75(11):5090-8.

22.

Characterization of viral double-stranded RNA-binding proteins.

Jacobs BL, Langland JO, Brandt T.

Methods. 1998 Jul;15(3):225-32.

PMID:
9735307
23.

Reovirus sigma 3 protein: dsRNA binding and inhibition of RNA-activated protein kinase.

Jacobs BL, Langland JO.

Curr Top Microbiol Immunol. 1998;233(Pt 1):185-96. Review. No abstract available.

PMID:
9599927
24.

Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells.

Rager KJ, Langland JO, Jacobs BL, Proud D, Marsh DG, Imani F.

J Virol. 1998 Feb;72(2):1171-6.

25.

Developmental regulation of a plant encoded inhibitor of eukaryotic initiation factor 2 alpha phosphorylation.

Langland JO, Langland L, Zeman C, Saha D, Roth DA.

Plant J. 1997 Aug;12(2):393-400.

26.

Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells.

Kibler KV, Shors T, Perkins KB, Zeman CC, Banaszak MP, Biesterfeldt J, Langland JO, Jacobs BL.

J Virol. 1997 Mar;71(3):1992-2003.

27.
29.
30.

Nucleic acid affinity chromatography: preparation and characterization of double-stranded RNA agarose.

Langland JO, Pettiford SM, Jacobs BL.

Protein Expr Purif. 1995 Feb;6(1):25-32.

PMID:
7538839
32.

TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR.

Park H, Davies MV, Langland JO, Chang HW, Nam YS, Tartaglia J, Paoletti E, Jacobs BL, Kaufman RJ, Venkatesan S.

Proc Natl Acad Sci U S A. 1994 May 24;91(11):4713-7.

33.

Supplemental Content

Loading ...
Support Center